Search
for
Sort by
Research 301–330 of 1000+
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Quiescent Tissue Stem Cells Evade Immune Surveillance
- Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle
- Pluripotent Stem Cell Technology: A Promising Remedy for Hypopigmentation Disorders
- Novel therapies for alopecia areata: The era of rational drug development
- T-Cell Reconstitution after Thymus Xenotransplantation Induces Hair Depigmentation and Loss
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- ALOPESİ AREATA TEDAVİSİNDE POTANSİYEL BAZI TIBBİ BİTKİ TÜRLERİNİN İNCELENMESİ
- Covid-19 in Lupus Nephritis
- Vitamin D and the Parenteral Nutrition Patient
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Thyroid hormone action on skin.
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Immunohistochemical assessment of SOX10 and its relation to the immune cellular infiltrate in alopecia areata follicles
- An Overview of Alopecias
- Hair loss
- Nails and hair
- Dermatoses of pregnancy
- Alopecia areata update
- Selected topics in pediatric hair loss
- Skin Diseases (Noncancerous)
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Clinical aspects of the metabolic syndrome
- Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors